Nanchang Gusen Biopharmaceutical Co., Ltd.

The headquarters of Nanchang Gusen Biopharmaceutical Co., Ltd. is located in Shanghai. The headquarters, Shanghai Gusen Pharmaceutical Co., Ltd. (Ningbo Hailingkang is intended to be its wholly-owned subsidiary), was founded by a Zhejiang Province "*" Distinguished Expert and their team, with high-end formulations, especially the new-generation high-efficiency inhalants—inhalation soft mist technology products—as the core, targeting European and American international development and industrialization, and jointly leveraging R&D platform resources such as Peking University, Fudan University, Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, and Shenyang Pharmaceutical University, to create and build a domestic first-class, * R&D team and R&D/industrialization base in this field, as well as an "industry-university-research" ecosystem. At the same time, it provides technical product solutions for the domestic and international high-end formulation/inhalant industry, provides high-quality and affordable medicines for the majority of patients, and elevates China's high-end formulations to a * level. v The company has R&D centers in Shanghai, Ningbo, and Nanchang, and has a pilot-scale and industrialization base in Nanchang. Three inhalation soft mist formulation products have been selected for the National 13th Five-Year "Major New Drug Creation" Science and Technology Major Project. The R&D and industrialization of inhalation soft mist formulations are at the forefront of domestic and international peers. The company has developed a rich product pipeline, with 5 first generic inhalation soft mist drugs under development, two of which are in the pilot stage. In addition, there are many backup products: 10 inhalation soft mist drugs are 505(b)(2) new drugs (domestic Class 2 new drugs), and all of these products have a global market of approximately 20 billion USD. The company has developed and applied for a series of inhalation soft mist patents, occupying the commanding heights in this field. It is the first domestic* enterprise to obtain a National "Major Project" for inhalation soft mist formulations.